HB1591 (2020) Compare Changes


The Bill Text indicates a new section is being inserted. This situation is not handled right now, and the new text is displayed in both the changed and unchanged versions.

Unchanged Version

Text to be removed highlighted in red.

1 Statement of Intent. The general court recognizes that the United States Surgeon General and the Centers for Disease Control and Prevention have concerns that perinatal exposure to cannabis increases the incidence of low birth weight infants and of subsequent learning disabilities. Therefore the general court hereby addresses these concerns.

2 New Subparagraphs; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8, XVI(c) by inserting after subparagraph (6) the following new subparagraphs:

(7) Information about the risks of cannabis use during pregnancy and while breastfeeding, including the risk of low birth weight and developmental issues. Such information shall include the posting of a warning poster regarding the risks of cannabis use during pregnancy and while breastfeeding in a conspicuous location at the alternative treatment center's dispensary location.

(8) Information regarding safe storage and disposal of cannabis and paraphernalia to prevent accidental poisonings, including the contact information for the Northern New England Poison Control Center.

3 New Paragraph; Use of Cannabis for Therapeutic Purposes; Duties. Amend RSA 132:2 by inserting after paragraph XI the following new paragraph:

XII. Prepare, in conjunction with the bureau of alcohol and drug services and the division of public health services, a brochure and a poster which provides information relative to the risks of cannabis use during pregnancy and while breastfeeding and which shall be posted and available to the public in all therapeutic cannabis dispensary locations pursuant to RSA 126-X:8.

4 Effective Date. This act shall take effect 60 days after its passage.

Changed Version

Text to be added highlighted in green.

1 Statement of Intent. The general court recognizes that the United States Surgeon General and the Centers for Disease Control and Prevention have concerns that perinatal exposure to cannabis increases the incidence of low birth weight infants and of subsequent learning disabilities. Therefore the general court hereby addresses these concerns.

2 New Subparagraphs; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8, XVI(c) by inserting after subparagraph (6) the following new subparagraphs:

(7) Information about the risks of cannabis use during pregnancy and while breastfeeding, including the risk of low birth weight and developmental issues. Such information shall include the posting of a warning poster regarding the risks of cannabis use during pregnancy and while breastfeeding in a conspicuous location at the alternative treatment center's dispensary location.

(8) Information regarding safe storage and disposal of cannabis and paraphernalia to prevent accidental poisonings, including the contact information for the Northern New England Poison Control Center.

3 New Paragraph; Use of Cannabis for Therapeutic Purposes; Duties. Amend RSA 132:2 by inserting after paragraph XI the following new paragraph:

XII. Prepare, in conjunction with the bureau of alcohol and drug services and the division of public health services, a brochure and a poster which provides information relative to the risks of cannabis use during pregnancy and while breastfeeding and which shall be posted and available to the public in all therapeutic cannabis dispensary locations pursuant to RSA 126-X:8.

4 Effective Date. This act shall take effect 60 days after its passage.